Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Renal Safety Evaluation After Dotarem®-Enhanced MRI Compared With Non-enhanced MRI in Patients at High Risk of Developing Contrast Medium Induced Nephropathy

NCT00650845 is registered in ClinicalTrials.gov with Guerbet as lead sponsor.

NCT NCT00650845
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00650845 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Renal Safety Evaluation After Dotarem®-Enhanced MRI Compared With Non-enhanced MRI in Patients at High Risk of Developing Contrast Medium Induced Nephropathy
Lead sponsor
Guerbet
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2008
Completion date
August 31, 2011
Enrollment
135 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

renal insufficiency